Nationwide Fund Advisors’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANGO
BC
RA
FWIA
Nationwide Fund Advisors's ANGO Position: Q4 2017 in Review
Nationwide Fund Advisors sold out of AngioDynamics (ANGO) in Q4 2017, closing a stake of 91,474 shares — an estimated $1.56M sold.
Nationwide Fund Advisors first reported a position in ANGO in Q2 2013 and held it in 18 quarters. The position peaked at $2.05M in Q3 2016. 169 funds tracked by Wall St. Rank hold ANGO as of Q4 2017.
- Nationwide Fund Advisors reported no remaining AngioDynamics position as of Q4 2017 after selling out during the quarter.
- Nationwide Fund Advisors sold 91,474 AngioDynamics shares in Q4 2017, an estimated $1.56M.
- Nationwide Fund Advisors first reported a position in AngioDynamics in Q2 2013 and held it in 18 quarters.
- Nationwide Fund Advisors's AngioDynamics position peaked at $2.05M in Q3 2016.
- 169 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2017.
Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.